Related Experiment Video
Updated: Jan 18, 2026
06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.4K
Chrysin-Loaded Micelles Regulate Cell Cycle and Induce Intrinsic and Extrinsic Apoptosis in Ovarian Cancer Cells
Serife Cakir1,2, Ummugulsum Yildiz1,2, Turgay Yildirim3
1Department of Biomedical Engineering, Erciyes University, 38039 Kayseri, Turkey.
Nanomaterials (Basel, Switzerland)
|September 12, 2025
Summary
This study introduces PMOD-Chr, a novel nanoparticle for ovarian cancer therapy. It effectively delivers chrysin (Chr) into cancer cells, enhancing treatment efficacy and triggering cell death.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Therapeutics
Background:
- Intracellular drug delivery for ovarian cancer is challenging.
- Developing effective nanoparticle platforms is crucial for targeted therapy.
Purpose of the Study:
- To engineer a multi-functional nanoparticle, PMOD-Chr, for enhanced intracellular delivery of chrysin (Chr) in ovarian cancer.
- To evaluate the efficacy of PMOD-Chr in ovarian cancer cells.
Main Methods:
- RAFT polymerization to synthesize p(MMA-co-DMAEMA)-b-(OEGMA-co-DMA) copolymer.
- Nanoprecipitation to form chrysin-loaded nanoparticles (PMOD-Chr).
- In vitro studies using A2780 and OVCAR3 ovarian cancer cells to assess cytotoxicity, cell cycle arrest, and apoptosis.
Main Results:
- PMOD-Chr nanoparticles (~220 nm) showed high homogeneity and spherical morphology.
- PMOD-Chr significantly enhanced chrysin cytotoxicity in ovarian cancer cells.
- PMOD-Chr induced G2/M cell cycle arrest and triggered apoptosis via both intrinsic and extrinsic pathways.
Conclusions:
- Precision engineering via RAFT polymerization yields sophisticated nanomedicines.
- PMOD-Chr effectively overcomes delivery barriers for ovarian cancer therapy.
- This nanoparticle platform offers a promising targeted strategy for ovarian cancer treatment.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
02:34Inhibition of Cdk Activity
5.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
01:17The Extrinsic Apoptotic Pathway
8.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K